213233
Lithium chloride
ReagentPlus®, 99%
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
A propos de cet article
Formule linéaire :
LiCl
Numéro CAS:
Poids moléculaire :
42.39
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-212-3
MDL number:
eCl@ss:
38050203
Assay:
99%
Form:
powder, crystals or granules
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderService technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderInChI key
KWGKDLIKAYFUFQ-UHFFFAOYSA-M
InChI
1S/ClH.Li/h1H;/q;+1/p-1
SMILES string
[Li+].[Cl-]
product line
ReagentPlus®
assay
99%
form
powder, crystals or granules
pH
6
mp
605 °C (lit.)
storage temp.
room temp
Quality Level
Vous recherchez des produits similaires ? Visite Guide de comparaison des produits
Catégories apparentées
Application
Lithium chloride can be used as a catalyst in the:
- Mukaiyama-type Mannich reaction of methylsilyl enol ethers with arylaldimines to synthesize β-amino carbonyl compounds.
- Microwave-irradiated chemo- and regioselective demethylation of aryl methyl ethers.
- Aza-Michael addition reaction of pyrazoles to α,β-unsaturated imides.
Other Notes
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
Classe de stockage
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Daniel I Perez et al.
Journal of medicinal chemistry, 54(12), 4042-4056 (2011-04-20)
Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, being one of the inhibitors on clinical trials for different tauopathies. Following
Alessandro Di Maio et al.
EvoDevo, 6, 17-17 (2015-07-15)
Wnt signaling is one of the earliest and most highly conserved regulatory pathways for the establishment of the body axes during regeneration and early development. In regeneration, body axes determination occurs independently of tissue rearrangement and early developmental cues. Modulation
A Abu-Baker et al.
Cell death & disease, 4, e821-e821 (2013-10-05)
Expansion of polyalanine tracts causes at least nine inherited human diseases. Among these, a polyalanine tract expansion in the poly (A)-binding protein nuclear 1 (expPABPN1) causes oculopharyngeal muscular dystrophy (OPMD). So far, there is no treatment for OPMD patients. Developing
A M Petrosyan et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 105, 623-625 (2013-02-07)
We argue that the recently reported crystals "L-threonine formate" as well as "L-alanine lithium chloride" and "bis L-alanine lithium chloride" actually are the well-known crystals L-threonine and L-alanine, respectively.
Aitor González et al.
PloS one, 8(1), e53323-e53323 (2013-01-18)
The mouse segmentation is established from somites, which are iteratively induced every two hours from the presomitic mesoderm (PSM) by a system known as the segmentation clock. A crucial component of the segmentation clock is the gene Hes7, which is
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique